| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.08 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |